Introduction
Several classes of glycosyltransferases have been found to consist of homologous gene families. In the case of β-1,4-galactosyltransferase (β-1,4-GalT) which transfers galactose from UDP-Gal to N-acetylglucosamine and N-acetylglucosamine-terminated oligosaccharides, seven members designated as β-1,4-GalTs I-VII form a gene family (reviewed in Amado et al., 1999; Furukawa and Sato, 1999) . Studies of in vitro acceptor specificities showed that β-1,4-GalTs II and V galactosylate N-acetylglucosamine terminated on N-linked oligosaccharides (Almeida et al., 1997; Sato et al., 1998b) ; β-1,4-GalTs IV and V galactosylate that on O-linked oligosaccharides (Ujita et al., 1998; van Die et al., 1999) ; β-1,4-GalTs III, IV, V, and VI galactosylate N-acetylglucosamine or glucose on glycolipids (Almeida et al., 1997; Nomura et al., 1998; Schwientek et al., 1998 , Takizawa et al., 1999 Sato et al., 2000a) ; and β-1,4-GalT VII, which fails to galactosylate N-acetylglucosamine but galactosylates xylose attached to proteoglycan core proteins Okajima et al., 1999) . However, these studies were accomplished with using either a soluble or membrane-bound form of each β-1,4-GalT and different assay conditions, and, therefore, their properties, including acceptor specificities, may not be compared directly among them.
Because the Galβ1→4GlcNAc structure on N-linked oligosaccharides from several tissues of β-1,4-GalT I-knockout mouse was detected (Asano et al., 1997; Kido et al., 1998 Kido et al., , 2000 , some of β-1,4-GalTs II-VI could be really involved in the galactosylation of N-linked oligosaccharides in vivo. To examine which of β-1,4-GalTs beside β-1,4-GalT I are involved in N-linked oligosaccharide biosynthesis in vivo, individual human β-1,4-GalT cDNAs were introduced into Sf-9 cells, which appeared to lack β-1,4-GalT but to contain UDP-Gal in the Golgi apparatus and the acceptor oligosaccharides in the endogenous glycoproteins (Hollister et al., 1998; Yoshimi et al., 2000) , and the galactosylation of membrane glycoproteins were examined by lectin blot analysis using RCA-I, which preferentially interacts with oligosaccharides terminated with the Galβ1→4GlcNAc group (Baenziger and Fiete, 1979) . To establish this further, antisense β-1,4-GalT cDNAs were introduced into human colorectal adenocarcinoma SW480 cells and the galactosylation of membrane glycoproteins was examined by lectin blot analysis. The present study showed that β-1,4-GalTs II, III, IV, V, and VI can galactosylate N-acetylglucosamine terminated on N-linked oligosaccharides.
Results

Expression of β-1,4-GalT proteins in Sf-9 cells
Because β-1,4-GalT II, III and IV transcripts were expressed in human erythroleukemic K562 cells (Sato et al., 2000b) , their full-length cDNAs were isolated from K562 cells by reversetranscription polymerase chain reaction (PCR) using oligonucleotide primers (shown in Materials and methods) specific 1 These authors contributed equally to this article. 2 To whom correspondence should be addressed to the human β-1,4-GalT II and III, and IV cDNAs already cloned by Almeida et al. (1997) and by Schwientek et al. (1998) , respectively, and sequenced. That the nucleotide sequences of human K562 β-1,4-GalTs III and IV match with those reported previously (Almeida et al., 1997; was confirmed. However, the nucleotide sequence of human K562 β-1,4-GalT II showed a difference in one position at 909 to that reported previously (Almeida et al., 1997) but made no change in the amino acid sequence.
To determine the nature of sugar-acceptor molecules of β-1,4-GalTs II-VI in vivo, the human β-1,4-GalT I to VI cDNAs were independently cloned into a pVL1393 vector, and the resultant plasmids were separately transfected into Sf-9 cells. As described already, a very weak β-1,4-GalT activity toward p-nitrophenyl-N-acetyl-1-thio-β-D-glucosaminide (GlcNAcβ-S-pNP) was detected in the homogenates from untransfected Sf-9 cells, which was slightly increased on transfection of a vector (less than 0.1 pmol galactose-transferred/ min-mg protein) as described previously (Sato et al., 1998a (Sato et al., , 2000a , while significantly higher transferase activities toward GlcNAcβ-S-pNP were detected in the homogenates from the cells transfected with the β-1,4-GalT I, II, III, IV, V, and VI cDNAs (0.43-1.11 nmol galactose-transferred/min-mg protein as obtained by three independent experiments), in which the titers of the viruses used for infection of the plasmids were adjusted. When [ 3 H]-galactosylated GlcNAcβ-S-pNP isolated from the assay mixtures of all samples was digested with diplococcal β-1,4-galactosidase, which specifically cleaves the Galβ1→4GlcNAc linkage but not the Galβ1→3GlcNAc linkage (Glasgow et al., 1977) , and then digests were applied to a Sep-Pak C 18 cartridge, all of the radioactivities were recovered in the pass-through fraction of the column (data not shown), indicating that galactose is transferred to the acceptor in a β-1,4-linkage. Kinetic studies showed that human recombinant β-1,4-GalTs possess apparent K m values of 42-105 µM toward UDP-Gal and of 63-238 µM toward GlcNAcβ-S-pNP (Table I ). The V max values were also determined using GlcNAcβ-S-pNP as a sugar acceptor to obtain kinetic efficiencies for individual β-1,4-GalTs, which showed that β-1,4-GalTs I and II can galactosylate the acceptor more effectively than other β-1,4-GalTs (Table I ). These results indicate that human β-1,4-GalTs I, II, III, IV, V, and VI can catalyze transfer of galactose from UDP-Gal to N-acetylglucosamine-terminated N-linked oligosaccharides with different efficiencies.
Lectin blot analysis of membrane glycoproteins from gene-transfected Sf-9 cells
It was shown that N-linked oligosaccharides from lepidopteran Sf-9 cells are mainly of high mannose-type (Kubelka et al., 1994; Marchal et al., 1999) . However, our lectin blot analysis of Sf-9 cell membrane glycoprotein samples revealed the presence of several protein bands reacted to Psathyrella velutina lectin (PVL) (Yoshimi et al., 2000) , which interacts with oligosaccharides terminated with β-N-acetylglucosamine (Endo et al., 1992) . Because PVL-positive bands disappeared on treatment of blots with N-glycanase, it was expected that Sf-9 cells contain complex-and/or hybrid-type oligosaccharides terminated with N-acetylglucosamine in addition to high mannose-type ones. Detailed structural analysis of N-linked oligosaccharides released by hydrazinolysis from Sf-9 cell membrane glycoprotein samples revealed that about 7% of the total oligosaccharides are of hybrid-type with the (Manα1→) 2 Manα1→6(3)[GlcNAcβ1→Manα1→3(6)]Manβ 1→GlcNAcβ1→GlcNAc structure and monoantennary complex-type with the [Manα1→6(3)][GlcNAcβ1→Man-α1→3(6)]Manβ1→GlcNAcβ1→(Fucα1→)GlcNAc structure (Yoshimi et al., 2000) . Because co-transfection of bovine β-1,4-GalT I cDNA with human tissue plasminogen activator cDNA into Sf-9 cells resulted in the β-1,4-galactosylation of N-linked oligosaccharides on vacurovirus virion glycoproteins and recombinant human tissue plasminogen activator (Hollister et al., 1998) , it appeared that Sf-9 cells contain a galactosylation machinery except for β-1,4-GalT. Therefore, it was expected that Sf-9 cells provide an useful cell line to investigate the in vivo acceptor specificities of β-1,4-GalTs II, III, IV, V, and VI.
Because β-1,4-GalT activities were detected in Sf-9 cells transfected with individual β-1,4-GalT cDNAs, whether or not each β-1,4-GalT is involved in the galactosylation of N-linked oligosaccharides was examined in the gene-transfected cells by lectin blot analysis of endogenous membrane glycoprotein samples that contained acceptor-substrates for β-1,4-GalT. No significant differences were observed in Coomassie Brilliant Blue (CBB) staining patterns among the samples except for 50 kDa and 53 kDa bands, which appeared in those from the Table I . Kinetic parameters of recombinant human β-1,4-GalTs Values are means of three independent experiments. Specific activities of individual β-1,4-GalTs expressed in Sf-9 cells by the experiments were 0.43-1.11 nmol galactose transferred/ min-mg protein. The molecular weights of RCA-I-positive bands appeared to be identical to those of PVL-positive bands as reported previously (Yoshimi et al., 2000) . The results indicate that β-1,4-GalTs I, II, III, and IV can galactosylate the endogenous glycoprotein acceptors, most probably hybrid-and/or monoantennary complex-type acceptor oligosaccharides more effectively than β-1,4-GalTs V and VI. Prolonged incubation (10 min) of blots with peroxidase-conjugated RCA-I resulted in the strong color development on several protein bands whose color intensities were not discriminated among the samples ( To confirm further that β-1,4-GalTs are involved in N-linked oligosaccharide biosynthesis in mammalian cells which contain some or all of β-1,4-GalTs, human antisense β-1,4-GalTs II and V cDNAs were independently transfected into human colorectal adenocarcinoma cell line, SW480, in which the gene expression levels of β-1,4-GalTs II and V were significant in addition to β-1,4-GalT I (Sato et al., 2000b) . Lectin blot analysis of membrane glycoprotein samples from the SW480 cells revealed that the binding to RCA-I is reduced in the samples from both antisense cDNA-transfected cells when compared with that of the control sample (Figure 2) . Because all the lectin-positive bands disappeared on treatment of blots with diplococcal β-1,4-galactos- (b) show that the blots were incubated with peroxidase-conjugated RCA-I in the presence of 4-chloro-1-naphthol for 1 min to minimize and for 10 min to maximize the color development, respectively. 
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Acceptor specificities of β-1,4-GalTs toward oligosaccharides with branched structures
Because all six human β-1,4-GalTs were shown to be able to galactosylate N-linked oligosaccharides, whether or not there are differences in acceptor specificities among β-1,4-GalTs was investigated using GlcNAcβ-S-pNP, GlcNAc, oligosaccharides with the GlcNAcβ1→2Manα1→3Man structure (oligosaccharide 3), with the GlcNAcβ1→4(GlcNAcβ1→2)Man branch (oligosaccharide 4) and with the GlcNAc-β1→6(GlcNAcβ1→2)Man branch (oligosaccharide 5) as acceptor substrates shown in Table II , and the homogenates of Sf-9 cells transfected with the individual β-1,4-GalT cDNAs as enzyme sources. Because specific activities of β-1,4-GalTs expressed in Sf-9 cells varied partly due to different titration levels of viruses transfected, the activities toward individual acceptor substrates were expressed as relative values to that toward GlcNAcβ-S-pNP. β-1,4-GalTs I and II galactosylated GlcNAcβ-S-pNP, oligosaccharides 4 and 5 quite effectively, but β-1,4-GalT I galactosylated GlcNAc more effectively than other acceptors while β-1,4-GalT II galactosylated GlcNAc less effectively than others ( Figure 3A) . β-1,4-GalT III galactosylated GlcNAcβ-S-pNP and oligosaccharides 4 and 5 effectively, oligosaccharide 3 less effectively, but not GlcNAc. In contrast, β-1,4-GalTs IV, V, and VI galactosylated GlcNAcβ-S-pNP and oligosaccharide 5 effectively but did so poorly for oligosaccharides 3 and 4. These transferases failed to galactosylate 1 mM GlcNAc. Because all six β-1,4-GalTs could galactosylate oligosaccharide 5 effectively, which of the N-acetylglucosamine residue of the branched oligosaccharide is galactosylated was determined by analyzing the mono-[ 3 H]galactosylated product by the method as described previously (Shirane et al., 1999) . β-1,4-GalT I preferentially galactosylated the GlcNAcβ1→2Man branch, and β-1,4-GalTs IV, V, and VI showed preferential galactosylation of the GlcNAcβ1→6Man branch ( Figure 3B ). No branch specificity was observed for β-1,4-GalTs II and III, which galactosylated both branches almost equally. In the case of oligosaccharide 4, branch specificities among six β-1,4-GalTs were not determined because some transferases showed lower activities. Although no oligosaccharides with biantennary structures were used for assays, β-1,4-GalTs I, II, and III galactosylated effectively asialo, agalacto-human transferrin having biantennary complex-type oligosaccharides but not β-1,4-GalTs IV and V (unpublished data), which was consistent to those reported previously . These results indicate that β-1,4-GalTs I-VI have different acceptor specificities toward oligosaccharides with the branched structures. Due to the limitted availability of oligosaccharides 3, 4, and 5, kinetic properties of the recombinant β-1,4-GalTs were unable to be determined. Table II . I-VI at the top of each panel in (A) indicate the enzyme sources prepared from Sf-9 cells transfected with the β-1,4-GalT I, II, III, IV, V, and VI cDNAs, respectively. In each case β-1,4-GalT activities toward acceptors 2-5 were expressed by taking the activity toward GlcNAcβ-S-pNP (acceptor 1) as 100%.
Discussion
In the present study, human β-1,4-GalTs I, II, III, IV, V, and VI were expressed as membrane-bound forms in Sf-9 cells and the galactosylation of endogenous membrane glycoproteins was examined by lectin blot analysis. Hardly any β-1,4-linked galactose residues on N-linked oligosaccharides were detected in Sf-9 cells by structural analysis (Yoshimi et al., 2000) and in mock-transfected cells, although very weak, β-1,4-GalT activities toward GlcNAcβ-S-pNP were detected in the both cells. In contrast, significantly higher levels of β-1,4-GalT activities toward GlcNAcβ-S-pNP and of β-1,4-linked galactose residues on N-linked oligosaccharides as revealed with binding to RCA-I were detected in the cells transfected with individual human β-1,4-GalT cDNAs. Because membrane glycoproteins of Sf-9 cells contain oligosaccharides with the Manα1→6(3)[GlcNAcβ1→Man-α1→3(6)]Manβ1→GlcNAcβ1→(Fucα1→)GlcNAc and (Manα1→)2Manα1→6(3)[GlcNAcβ1→Manα1→3(6)]Manβ 1→GlcNAcβ1→GlcNAc structures (Yoshimi et al., 2000) , the N-acetylglucosamine residues of the oligosaccharides should have been galactosylated by all six β-1,4-GalTs. In fact, protein bands with apparent molecular weights of 35 kDa and 60 kDa that reacted strongly with RCA-I were detected in all the samples. However, differences in the initial color development on these protein bands as shown in Figure 1 RCA-I (a) indicate that β-1,4-GalTs I, II, III, and IV can galactosylate monoantennary-and hybrid-type acceptor oligosaccharides more effectively than β-1,4-GalTs V and VI. Other differences in the reactivity and number of the lectin-positive bands among the samples could be reflected by differences in the kinetic parameters and acceptor specificities of individual β-1,4-GalTs. In this regard, our preliminary studies suggested that N-linked oligosaccharides of Sf-9 cells contain yet unidentified structures having N-acetylglucosamine residue(s) at their nonreducing termini. Therefore, it is of importance to elucidate structures of such oligosaccharides to confirm the fine acceptor specificities of individual β-1,4-GalTs expressed in Sf-9 cells.
Analysis of acceptor-specificity of β-1,4-GalT IV expressed in a soluble form showed no capability of galactosylating glycoprotein acceptors . Similarly, in a purified chimeric protein of human β-1,4-GalT V with protein A, the transferase also failed to galactosylate glycoprotein acceptors (unpublished data). However, the present study clearly demonstrated that β-1,4-GalTs IV and V expressed as membrane-bound forms in Sf-9 cells can galactosylate the endogenous N-linked oligosaccharides. Because some lipid-rich environment stimulated β-1,4-GalT I activities (Mitranic and Moscarello, 1980; Mitranic et al., 1983) , most of these β-1,4-GalTs may require such an environment for maintaining proper tertial structures that affect their acceptor specificities. It is of interest to investigate whether or not the purified recombinant human β-1,4-GalTs in membrane-bound forms can galactosylate glycoprotein acceptors effectively in the presence of some types of lipids. Similarly, several studies showed that β-1,4-GalTs III, IV, and VI are involved in the biosynthesis of glycolipids such as lactosylceramide and lacto-N-neotetraosylceramide in vitro (Almeida et al., 1997; Nomura et al., 1998; Schwientek et al., 1998; Takizawa et al., 1999) , but the present study showed that they can also galactosylate N-linked oligosaccharides in vivo. Because they are supposed to be in the trans-Golgi (Roth and Berger, 1982) in which the galactosylation of N-linked oligosaccharides but not of glucosylceramide takes place, β-1,4-GalTs III, IV, and VI may not be involved in the biosynthesis of lactosylceramide in vivo. Concerning to this issue, it is important to elucidate the fine localization of individual β-1,4-GalTs within the Golgi apparatus once antibodies specific to individual β-1,4-GalTs are available, and it is of interest to investigate whether the galactosylation of glycolipids is also enhanced in Sf-9 cells on transfection of individual β-1,4-GalT cDNAs if appropriate endogenous precursor substrates such as glucosylceramide and lacto-N-triaosylceramide are accumulated in Sf-9 cells.
The present study also demonstrated that β-1,4-GalT I prefers to galactosylate the GlcNAcβ1→2Man branch and β-1,4-GalTs IV, V, and VI galactosylate the GlcNAcβ1→6Man branch predominantly, whereas no preference is observed for β-1,4-GalTs II and III. In the case of β-1,4-GalT V, prolonged incubation showed no galactosylation of another N-acetylglucosamine residue of oligosaccharide 5, indicating that other β-1,4-GalTs could galactosylate it. Using oligosaccharides with the Galβ1→4GlcNAcβ1→2(GlcNAcβ1→6)Man and Galβ1→4GlcNAcβ1→6(GlcNAcβ1→2)Man structures, β-1,4-GalT I was shown to galactosylate the GlcNAcβ1→6Man branch more effectively than the GlcNAcβ1→2Man branch of the monogalactosylated oligosaccharides , indicating that the initial galactosylation affects the subsequent galactosylation of the branched oligosaccharides. Therefore, it is worthy of determining the order of β-1,4-GalTs for the galactosylation of all of N-acetylglucosamine residues of highly branched oligosaccharides. In the case of β-1,4-GalT I-knockout mouse, polysialic acid, which is supposed to be expressed on highly branched N-linked oligosaccharides (Kudo et al., 1996) , was expressed without reduction when compared to that of wildtype mouse (Kido et al., 1998) , suggesting that β-1,4-GalTs II to VI are involved in the galactosylation of the highly branched oligosaccharides. In support of our findings in the present study, some or all of β-1,4-GalTs II, III, IV, V, and VI have been recently shown to be invovled in the galactosylation of highly branched N-linked oligosaccharides using Chinese hamster ovary mutant cell lines (Lee et al., 2001) .
The tissue-specific expression of β-1,4-GalTs II, III and IV in human tissues (Almeida et al., 1997; Lo et al., 1998; Sato et al., 1998b; Schwientek et al., 1998; Takizawa et al., 1999) suggests that they are contributing to tissue-specific galactosylation of N-linked oligosaccharides. Interestingly, the gene expression level of β-1,4-GalT V but not β-1,4-GalTs IV and VI, whose transcripts were under detection levels was increased on malignant transformation of NIH3T3 cells (Shirane et al., 1999; Sato et al., 2000b) , indicating that β-1,4-GalT V is mainly involved in the galactosylation of the GlcNAcβ1→6Man branch, on which a variety of tumor antigens are expressed and involved in metastasis (Dennis et al., 1987; Dennis and Laferte, 1989; Ohyama et al., 1999) . Further investigation is necessary as to whether suppression of the β-1,4-GalT V gene expression will result in the reduction of the tumor formation and/or tumor metastatic processes to show functions of the carbohydrates. Finally, to raise and to analyze phenotypes of individual β-1,4-GalT-knockout mice will contribute to our real understandings how individual β-1,4-GalTs are important for our lives as already shown in β-1,4-GalT I-knockout mouse (Asano et al., 1997; Lu et al., 1997) . 4 (490 mCi/mmol) were purchased from NEN-Life Science Products (Boston, MA). GlcNAcβ1→2Manα1→3Manβ1→O(CH 2 ) 8 COOCH 2 -m-nitrophenol (mNP), GlcNAcβ1→4(GlcNAcβ1→2)Manα1→3Manβ1→O(CH 2 ) 8 COOCH 2 -mNP, and GlcNAcβ1→6(GlcNAcβ1→2)Manα1→3Manβ1→O(CH 2 ) 8 COOCH 2 -mNP, which were chemically synthesized and donated by Dr. T. Kitajima, Towa Kasei Co. (Japan), and GlcNAcβ-S-pNP and UDP-Gal were purchased from Sigma Chemical Co. (St. Louis, MO). Diplococcal β-1,4-galactosidase was obtained from Roche Molecular Biochemicals (Mannheim, Germany), and N-glycanase was a gift from Dr. T. Kaizu formerly in Genzyme Japan (Tokyo). Peroxidase-conjugated RCA-I was purchased from Honen Oil Co. (Tokyo).
Materials and methods
Chemicals
Isolation of human β-1,4-GalT II, III, and IV cDNAs
The total RNA preparation was obtained from human erythroleukemic K562 cells with RNeasy Total RNA System (QIAGEN) from which single-strand cDNAs were prepared using a hexadeoxyribonucleotide mixture [pd (N) 6 , TAKARA] as a primer and Ready-To-Go™ You-Prime First Strand Beads (Pharmacia Biotech). The cDNAs encoding the full length of human β-1,4-GalTs II, III, and IV were amplified by polymerase chain reaction (PCR) (95°C, 10 min [94°C, 0.5 min; 60°C, 0.5 min; and 72°C, 1.5 min] × 40, and 72°C, 15 min) using AmpliTaq Gold™ (Perkin Elmer), the singlestrand cDNAs as a template and 5′-and 3′-primers specific for each β-1,4-GalT. The following 5′-and 3′-primer pairs were used (the newly synthesized BamH I, EcoR l and Xba I sites in the primers are underlined):
• TS49 (5′-CGGGATCCTTGCGGGATGAGCAGACTG-3′) and TS50 (5′-CGGAATTCCATTAGTGTCAGCCCCGAG-3′) for β-1,4-GalT II • TS51 (5′-CGGGATCCAGGATGTTGCGGAGGCTG-3′) and TS52 (5′-GCTCTAGAGGAGTCAGTGTGAACCTC-3′) for β-1,4-GalT III • TS53 (5′-CGGGATCCAACATGGGCTTCAACCTGAC-3′) and TS54 (5′-CGGAATTCAGGGTCATGCACCAAACCAG-3′) for β-1,4-GalT IV PCR products were cloned into pGEM-T Easy vector (Promega) and sequenced. The nucleotide sequences of human β-1,4-GalT II, III, and IV cDNAs isolated in the present study were deposited in the DDBJ/GenBank/ EMBL data base (accession numbers: AB024434, AB024435, and AB024436, respectively).
Plasmid construction and expression of β-1,4-GalT cDNA in Sf-9 and SW480 cells Plasmid containing each β-1,4-GalT cDNA was digested with BamH l and EcoR l or BamH l and Xba l, and the fragment was ligated into the BamH l-EcoR l or BamH l-Xba l site of baculovirus transfer vector pVL1393 (Pharmingen). The resultant plasmids, pVL1393/β-1,4-GalT II, pVL1393/β-1,4-GalT III, and pVL1393/β-1,4-GalT IV, were transfected independently with BaculoGold™ Linearized Baculovirus DNA into Sf-9 cells by the method described in BaculoGold™ system's protocol (Pharmingen). Recombinant baculoviruses were obtained after two successive amplification in Sf-9 cells.
Similarly, plasmids, pVL1393/β-1,4-GalT I, pVL1393/β-1,4-GalT V and pVL1393/β-1,4-GalT VI were also transfected independently into the cells as described previously (Sato et al., 1998a (Sato et al., , 2000a Sato and Furukawa, 1999) . The titers of the viruses to be used for infection to Sf-9 cells (9 × 10 6 cells/10 cm φ) were determined with monitoring the enzyme activities of individual β-1,4-GalTs.
Human colorectal adenocarcinoma cell line, SW480, was obtained from the Institute of Development, Aging and Cancer, Tohoku University, Sendai, and grown at 37°C in RPMI1640 containing 10% fetal calf serum, 50 units/ml penicillin, and 50 mg/ml streptomycin. Fragments containing a partial coding sequence of human β-1,4-GalT II (-5 to 500) and a partial coding sequence of human β-1,4-GalT V (-5 to 500) were subcloned in an antisense orientation into a mammalian expression vector, pcDNA3.1 (Invitrogen), and the expression vectors were named pcDNA3.1/GTII AS and pcDNA3.1/GTV AS, respectively. For transfection, 1 × 10 5 SW480 cells were seeded in tissue culture dishes with a diameter of 35 mm and cultured 37°C for 24 h in a CO 2 incubator. Two micrograms of pcDNA3.1, pcDNA3.1/GTII AS, or pcDNA3.1/GTV AS formulated with a FuGENE reagent (Boehringer Mannheim, Mannheim, Germany) was added to the cells grown at the 60-70% confluent stage and cultured for 72 h. The plasmid-transfected cells were selected with a medium containing geneticin (700 µg/ml G418 sulfate, Sigma) for 2 weeks.
Determination of β-1,4-GalT activities
The harvested cells were washed with phosphate buffered saline (pH 7.2) three times, suspended in 100 mM 2-(Nmorpholino)ethansulfonic acid (MES) buffer (pH 7.0) containing 1.25% Triton X-100, and then sonicated. The cell homogenates were used for transferase assays as an enzyme source. β-1,4-GalT activities were determined by the method described previously (Sato et al., 1998b) . In all instances the reaction mixture contained 100 mM MES buffer (pH 7.0) containing 4 mM 5′-AMP, 250 mM UDP-[ 3 H]Gal, 1 mM appropriate acceptor, 20 mM MnCl 2 , and enzyme preparation in a total volume of 50 µl. After incubation the product was isolated by using a Sep-Pak C 18 cartridge or an AG ×1 column (Cl -form), and radioactivity incorporated into the product was determined. To diminish or inhibit β-N-acetylhexosaminidase activity possibly present in the cell homogenates (Kubelka et al., 1994) , pH of the assay mixture was adjusted to 7.0 rather than 6.0, at which maximal activities of β-1,4-GalT (Furukawa and Roth, 1985) and β-N-acetylglucosaminidase were obtained (Altman et al., 1995) , and, in some assays, 2 mM N-acetylglucosamine was included in the reaction mixture (Bendiak and Schachter, 1987) .
Lectin blot analysis of membrane glycoproteins
Lectin blot analysis of membrane glycoprotein samples from Sf-9 cells and gene-transfected cells was performed as described previously (Sato et al., 1993) . Membrane glycoproteins were separated by 7.5% polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate according to the method of Laemmli (1970) , and separated proteins were electrophoretically transferred to polyvinylidenedifluoride membranes by the method described previously (Towbin et al., 1979) . Blotted membranes were blocked with 1% bovine serum albumin and incubated with peroxidase-conjugated RCA-I. In some experiments, blotted membrane blocked with bovine serum albumin was treated with 3.5 U N-glycanase in 150 µl of 0.1 M phosphate buffer (pH 8.2), 1.0 U of jackbean β-N-acetylhexosaminidase in 150 µl of 0.3 M citratephosphate buffer (pH 5.0), or 40 mU of diplococcal β-1,4-galactosidase in 150 µl of 0.3 M citrate-phosphate buffer (pH 6.0) per one lane at 37°C for 24 h before incubation with lectin.
